Targeting CD155 by rediocide-A overcomes tumour immuno-resistance to natural killer cells

• Main Authors: Wanyi Ng (Author), Chenyuan Gong (Author), Xuewei Yan (Author), Guifan Si (Author), Chen Fang (Author), Lixin Wang (Author), Xiaowen Zhu (Author), Zihang Xu (Author), Chao Yao (Author), Shiguo Zhu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Context Therapeutic benefits of immunotherapy are restricted by cancer immune-resistance mechanisms. Rediocide-A (Red-A), a natural product extracted from Traditional Chinese Medicine, is a promising agent to battle against cancer which acts as an immune checkpoint inhibitor. Objective To investigat...